Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.
about
Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistanceEffective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin BGenotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.In vivo functional and molecular characterization of the Penicillin-Binding Protein 4 (DacB) of Pseudomonas aeruginosa.Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strainsStructural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa.An rhs gene of Pseudomonas aeruginosa encodes a virulence protein that activates the inflammasome.Structural and functional characterization of Pseudomonas aeruginosa global regulator AmpR.Distinct roles of major peptidoglycan recycling enzymes in β-Lactamase production in Shewanella oneidensisInterplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolatesAmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.The β-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptideSublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilmsPseudomonas aeruginosa: resistance to the maxInfluence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.Mechanisms of antimicrobial resistance in Gram-negative bacilli.Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.Cell Wall Recycling-Linked Coregulation of AmpC and PenB β-Lactamases through ampD Mutations in Burkholderia cenocepacia.Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutationMolecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.Identification of MupP as a New Peptidoglycan Recycling Factor and Antibiotic Resistance Determinant in Pseudomonas aeruginosa.Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1.How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan)Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.AmpC beta-lactamases.Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway.Bacterial cell-wall recycling.PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway?Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.The extended-spectrum AmpC genotype of Pseudomonas aeruginosa strains from Egypt: an underlying threat to anti-pseudomonal treatment options.
P2860
Q27644480-A2E967EA-B444-402E-84F7-58A19F887DA6Q28478261-5CFA4096-B964-4D13-AFF0-1E2B40E78503Q30278439-C7E3C94B-A2A9-417B-A7AA-81E8F80EE138Q30819461-E197C444-72ED-4FD8-B016-9193F456A72BQ33422951-F81C9D52-0643-4882-A803-B558DA4C969DQ33613660-5634F922-6244-401A-BF45-917D7D161B3BQ33798601-E1B6D8E9-94F7-43E6-8624-03F3D2FB268EQ34167642-1A1CE950-D0A4-4FDA-AEEB-067869F97B32Q34246078-79F89586-9683-4204-A5BC-F039F081FEF2Q34593307-771BE007-32C9-4D77-BA5C-B52916AC9D60Q34596697-B0DEE4D9-B3EE-4211-9DAF-78E03DC60385Q34648729-987E7D89-31BE-486D-B060-9C538065A246Q34933120-60AE2AFF-EEA1-48DB-A8AA-CBF68ABF2136Q35007624-793A02F7-FF7F-4CF9-950B-EAA70B69DCD5Q35048806-FC00E18B-4AB1-47C2-8BB8-9B033E83B3E2Q35076815-C306308D-0E90-4231-9ED0-BDBB9E574C48Q35084559-0F51123A-139A-4478-9468-ABFBB84AF32CQ35879111-D43F2338-4E84-48D1-B5D8-CF262D1CB705Q35935319-2AFE6D12-AC4E-48D0-B1D1-9C06A5F468D0Q36095041-C578D506-FFCB-4A48-A39D-8D4409A86F8EQ36172484-F82C884F-724E-41D1-89F1-C8D93B0B5053Q36290729-44366B0F-9AA5-43BE-B926-F458691BB0E9Q36295397-06A70284-0A7E-4A25-8080-7705A5CBC8DFQ36313186-29B2C286-B5FC-4F2D-9C64-885622E5CC2FQ36326129-4949F14B-76E6-4898-84F6-30B8D02BB463Q36571851-5089E179-B67D-406B-A1B7-0117C0FF72D9Q37183911-76D1C73A-ED75-45C2-864E-2A2EAAEB8AEBQ37302114-9B0A9092-3C63-4ED5-A479-F08EC7ED4762Q37366249-7C9C04E9-2322-47F8-B55E-7DBC8C97C07AQ37643058-BB8360CC-9F97-4070-BA31-5F029539DD45Q37961906-F6A317D2-EF58-4BDB-992F-45466C4B64A8Q38060821-51910244-994B-4537-9148-B26AA6C45788Q38309969-5F140237-DBAD-4929-9405-6AAA5167C0FAQ38599969-90B066E2-0045-4EB7-8099-15F6F97D6EF7Q38626934-512B2651-FB34-4F28-9D7C-8719351B360CQ38664871-F78B30C5-53BC-4D87-A922-A62260A5A56CQ38802410-6F371116-44EF-491D-AA61-319BE0A1FB00Q38856197-64C101FF-9FE7-4BEF-BA51-CD94641AA2FBQ38981397-B8A3E93D-2EAD-41C3-A1F5-375EE4852736Q38988534-321516C7-E587-48E8-A01A-E12AFD6791FB
P2860
Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.
@en
Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.
@nl
type
label
Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.
@en
Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.
@nl
prefLabel
Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.
@en
Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.
@nl
P2093
P2860
P1476
Molecular mechanisms of beta-l ...... as aeruginosa clinical strains
@en
P2093
Antonio Oliver
Carmen Vidal
José L Pérez
Olivia Gutiérrez
P2860
P304
P356
10.1128/AAC.49.11.4733-4738.2005
P407
P577
2005-11-01T00:00:00Z